Yahoo
HKSE - Delayed Quote HKD

Essex Bio-Technology Limited (1061.HK)

2.045 +0.025 (+1.24%)
At close: November 10 at 4:08:34 PM GMT+8
View in AlphaSpace Currency in HKD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
1,721,966.257 1,813,807.257 1,669,816.770 1,736,972.134 1,317,710.616
Cost of Revenue
-226,423.227 -195,921.227 -171,154.250 -174,943.412 -128,381.601
Gross Profit
1,495,543.030 1,617,886.030 1,498,662.520 1,562,028.722 1,189,329.015
Selling, General and Administrative Expenses
-1,159,425.188 -1,207,408.188 -1,148,128.547 -1,228,963.269 -914,189.203
Other Income/Expense, Operating
2,333.818 2,974.818 4,550.475 1,351.024 6,316.822
Operating Income/Expenses
-1,157,091.370 -1,204,433.370 -1,143,578.072 -1,227,612.245 -907,872.381
Total Operating Profit/Loss
338,451.660 413,452.660 355,084.448 334,416.477 281,456.634
Total Net Finance Income/Expense
4,358.734 4,013.734 5,359.105 1,131.225 -2,594.498
Net Investment Income
-666.711 -2,116.711 -1,980.386 11,080.964 6,579.284
Irregular Income/Expenses
10,936.314 -5,968.686 11,076.477 -5,049.442 -38,842.092
Other Income/Expense, Non-Operating
5,977.303 5,281.303 5,960.587 4,435.203 13,743.452
Non-Operating Income/Expenses, Total
20,605.640 1,209.640 20,415.783 11,597.950 -21,113.854
Pretax Income
359,057.300 414,662.300 375,500.231 346,014.427 260,342.780
Provision for Income Tax
-93,647.137 -96,571.137 -68,278.413 -70,754.810 -34,931.470
Net Income from Continuing Operations
265,410.163 318,091.163 307,221.818 275,259.617 225,411.310
Net Income after Extraordinary Items and Discontinued Operations
265,410.163 318,091.163 307,221.818 275,259.617 225,411.310
Net Income after Non-Controlling/Minority Interests
265,410.163 318,091.163 307,221.818 275,259.617 225,411.310
Net Income Available to Common Stockholders
265,410.163 318,091.163 307,221.818 275,259.617 225,411.310
Dilution to Earnings
379.692 -- 2,464.692 4,123.105 4,047.963
Diluted Net Income Available to Common Stockholders
265,410.163 318,091.163 309,686.510 279,382.722 229,459.273
Common Dividend per Share
0.12 0.14 0.12 0.09 0.07
Basic EPS
0.47 0.56 0.54 0.48 0.39
Diluted EPS
0.47 0.56 0.53 0.47 0.38
Basic Weighted Average Shares Outstanding
566,988.626 567,020.515 567,489.139 570,222.501 573,964.430
Diluted Weighted Average Shares Outstanding
566,988.626 567,020.515 582,319.647 595,646.229 599,388.158
Income Statement, Supplemental
EBIT
354,698.566 410,648.566 370,141.126 344,883.202 262,937.278
EBITDA
424,495.226 473,240.226 426,014.080 404,759.512 304,850.215
Normalized EBITDA
419,901.924 474,587.410 421,114.613 407,516.223 339,276.746
Normalized Income
262,014.858 319,124.600 303,213.236 277,452.622 258,684.420
12/31/2022 - 6/27/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: